Key result
A 12-week yoga intervention significantly decreased depressive symptoms in patients with Major Depressive Disorder (p=0.0001) and normalized thalamic GABA levels compared to healthy controls.
Why the study?
Does a 12-week yoga intervention improve thalamic GABA levels and depressive symptoms in patients with Major Depressive Disorder compared to healthy controls?
RCT (n=32)
Does a 12-week yoga intervention improve thalamic GABA levels and depressive symptoms in patients with Major Depressive Disorder compared to healthy controls?
p-value: p=0.0001
A 12-week yoga intervention is associated with increased thalamic GABA levels and significant improvements in mood and anxiety in patients with Major Depressive Disorder.
Supports adjunctive yoga for MDD; extends RCT evidence by linking symptom relief to thalamic GABA normalization.
Objective: The Vagal-Gamma-Aminobutyric Acid (GABA) theory proposes that some yoga postures and breathing practices exert their effects through stimulation of vagal nerves (parasympathetic system) with associated brain GABA increases. To evaluate this theory, we compared results from a 12-week randomized controlled trial (RCT) of yoga in participants with Major Depressive Disorder (MDD) with those of a similar RCT in healthy control participants (HC). Methods: In an RCT, magnetic resonance spectroscopy (MRS) and mood measures were acquired in subjects with MDD (n=15) prior to and following a 12-week yoga intervention. The same measures were obtained in the HC (n=17) group. In both studies, thalamic GABA/Creatine was obtained using MEGAPRESS at 4 Telsa at baseline (Scan-1), post-intervention (Scan-2), and immediately following a yoga session (Scan-3). Clinical scales were completed prior to each scan. Results: The MDD-group had significantly lower GABA compared to the HC at baseline (Scan-1, p=0.001), but not after 12 weeks of yoga, either before (Scan-2, p=0.12) or after a yoga session (Scan-3, p=0.20). Depressive symptoms decreased significantly in the MDD-group (p=0.0001), and anxiety improved in both groups. Conclusion: After a 12-week yoga intervention, MDD-group mood and anxiety measures improved with scores equivalent to those of non-depressed individuals. This study provides the first evidence of brain GABA increases associated with specific yoga postures and breathing practices in MDD. These results suggest potential benefits of specific yoga postures and breathing practices as monotherapy or augmentation to other treatments to reduce anxiety and depression in MDD.
No takes yet. Share an insight, caveat, or question.
Streeter et al. (2018) conducted an RCT in Major Depressive Disorder (n=32). Yoga vs. Healthy controls was evaluated on Thalamic GABA/Creatine levels and depressive symptoms (p=0.0001). A 12-week yoga intervention significantly decreased depressive symptoms in patients with Major Depressive Disorder (p=0.0001) and normalized thalamic GABA levels compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: